Clinical Trial Update: COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RA [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating COBRA-Slim with or without fast access to TNF blockade for remission induction in early rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• COBRA-Slim (COBRA-Slim)

Snippet

Sponsor: P. Verschueren | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2025-06-19